Evidence map›Paper›PMID 28367453›Full record

ArticleJournal of immunology research2017

De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.

Michela Cioni, Arcangelo Nocera, Annalisa Innocente, Augusto Tagliamacco, Antonella Trivelli, Sabrina Basso, Giuseppe Quartuccio, Iris Fontana, Alberto Magnasco, Francesca Drago and 10 more

Abstract read
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Michela CioniNephrology, Dialysis and Transplantation Unit, IRCCS Istituto G. Gaslini, Genova, Italy.
Arcangelo NoceraClinical Nephrology Unit and Transplant Immunology Research Laboratory, Department of Internal Medicine, University of Genova and IRCCS San Martino University Hospital IST, Genova, Italy.
Annalisa InnocenteTransplantation Immunology, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Augusto TagliamaccoClinical Nephrology Unit and Transplant Immunology Research Laboratory, Department of Internal Medicine, University of Genova and IRCCS San Martino University Hospital IST, Genova, Italy.
Antonella TrivelliNephrology, Dialysis and Transplantation Unit, IRCCS Istituto G. Gaslini, Genova, Italy.
Sabrina BassoPediatric Hematology/Oncology and Cell Factory, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Giuseppe QuartuccioPediatric Hematology/Oncology and Cell Factory, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Iris FontanaVascular and Endovascular Unit and Kidney Transplant Surgery Unit, University of Genova, IRCCS San Martino University Hospital IST, Genova, Italy.
Alberto MagnascoNephrology, Dialysis and Transplantation Unit, IRCCS Istituto G. Gaslini, Genova, Italy.
Francesca DragoTransplantation Immunology, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Antonella GurradoPediatric Hematology/Oncology and Cell Factory, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Ilaria GuidoPediatric Hematology/Oncology and Cell Factory, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Francesca CompagnoPediatric Hematology/Oncology and Cell Factory, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Giacomo GaribottoClinical Nephrology Unit and Transplant Immunology Research Laboratory, Department of Internal Medicine, University of Genova and IRCCS San Martino University Hospital IST, Genova, Italy.
Catherine KlersyBiometry and Statistics Service, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Enrico VerrinaNephrology, Dialysis and Transplantation Unit, IRCCS Istituto G. Gaslini, Genova, Italy.
Gian Marco GhiggeriNephrology, Dialysis and Transplantation Unit, IRCCS Istituto G. Gaslini, Genova, Italy.
Massimo CardilloTransplantation Immunology, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Patrizia ComoliPediatric Hematology/Oncology and Cell Factory, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.ORCID 0000-0001-5964-0553
Fabrizio GinevriNephrology, Dialysis and Transplantation Unit, IRCCS Istituto G. Gaslini, Genova, Italy.ORCID 0000-0003-2377-8774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

De novo posttransplant donor-specific HLA-antibody (

Indexed as

AdolescentAge FactorsChildComplement C1qComplement C3dFemaleGraft RejectionHLA AntigensHumansIsoantibodiesKidney TransplantationLongitudinal StudiesMaleRetrospective StudiesRisk FactorsTissue DonorsComplement C1qComplement C3dHLA AntigensIsoantibodies

Identifiers

PMID28367453
PMCPMC5358457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.